Novel Use of Targeted Therapy via PARP-Inhibition in a Rare Form of Papillary Renal Cell Carcinoma: A Case Report and Literature Review

Daniel Olson*, Savita Bhalla, Ximing Yang, Brenda Martone, Timothy M. Kuzel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)e445-e448
JournalClinical Genitourinary Cancer
Issue number4
StatePublished - Aug 1 2016


  • Ataxia Telangiectasia Mutated
  • Next generation sequencing
  • Oncocytic Papillary Renal Cell Carcinoma
  • PARP inhibitor
  • Veliparib

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this